Showing results (321-330 of 411) with videos related to
Sort By:
Pageof 42
Brain Communications|July 11, 2025
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Lianne M Reus, et al.Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Genomics link obesity and type 2 diabetes to Alzheimer's disease to unveil novel biological insightsCésar Cunha, Mario Garcia-Ureña, Raquel Sanz Martĺnez, et al.JAMA|July 23, 2009
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairmentNiklas Mattsson, Henrik Zetterberg, Oskar Hansson, et al.Dementia and Geriatric Cognitive Disorders|May 9, 2013
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA studyMarinella Damian, Lucrezia Hausner, Katrin Jekel, et al.Journal of Alzheimer'S Disease : JAD|February 6, 2013
The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA StudyAngelique P A Vermeiren, Hans Bosma, Pieter-Jelle Visser, et al.Journal of Alzheimer'S Disease : JAD|April 9, 2019
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's DiseaseMoira Marizzoni, Clarissa Ferrari, Ambra Macis, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.Neurobiology of Aging|February 8, 2020
CSF cutoffs for MCI due to AD depend on APOEε4 carrier statusMoira Marizzoni, Clarissa Ferrari, Claudio Babiloni, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's diseaseEleonora M Vromen, Senne B Lageman, Johan Gobom, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.Pageof 42